This novel approach shows potential to improve effectiveness in metastatic breast cancer, suggesting wider applications for treatment.
This novel glucose-targeted liposomal approach shows potential to improve therapeutic specificity and efficacy in metastatic breast cancer. Further in vitro, in vivo, and clinical studies are warranted to validate its effectiveness and explore applicability to other solid tumors.
No takes yet. Share an insight, caveat, or question.
Shirbache et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: